Evidence map›Paper›PMID 35055245›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Natural Polyphenol-Containing Gels against HSV-1 Infection: A Comparative Study.

Mariaconcetta Sicurella, Maddalena Sguizzato, Paolo Mariani, Alessia Pepe, Anna Baldisserotto, Raissa Buzzi, Nicolas Huang, Fanny Simelière, Sam Burholt, Peggy Marconi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Mariaconcetta SicurellaDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, I-44121 Ferrara, Italy.
Maddalena SguizzatoDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, I-44121 Ferrara, Italy.ORCID 0000-0002-2100-2043
Paolo MarianiDepartment of Life and Environmental Sciences, Università Politecnica delle Marche, I-60131 Ancona, Italy.ORCID 0000-0003-4293-1009
Alessia PepeDepartment of Life and Environmental Sciences, Università Politecnica delle Marche, I-60131 Ancona, Italy.ORCID 0000-0002-7739-4488
Anna BaldisserottoDepartment of Life Sciences and Biotechnology, University of Ferrara, I-44121 Ferrara, Italy.ORCID 0000-0002-2882-3530
Raissa BuzziDepartment of Life Sciences and Biotechnology, University of Ferrara, I-44121 Ferrara, Italy.
Nicolas HuangCNRS, Institut Galien Paris-Saclay, Université Paris-Saclay, 92296 Châtenay-Malabry, France.ORCID 0000-0003-2750-3778
Fanny SimelièreCNRS, Institut Galien Paris-Saclay, Université Paris-Saclay, 92296 Châtenay-Malabry, France.
Sam BurholtDiamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0DE, UK.
Peggy MarconiDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, I-44121 Ferrara, Italy.ORCID 0000-0003-3488-0491
Elisabetta EspositoDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, I-44121 Ferrara, Italy.ORCID 0000-0002-8416-3629
University of Ferrara · ITCentre National de la Recherche Scientifique · FRMarche Polytechnic University · ITDiamond Light Source · GB

Funding

Engineering and Physical Sciences Research Council EP/R042683/1University of Ferrara FAR 2019
6 · The paper itself

Abstract

Herpes simplex virus type 1 infection commonly affects many people, causing perioral sores, as well as severe complications including encephalitis in immunocompromised patients. The main pharmacological approach involves synthetic antiviral drugs, among which acyclovir is the golden standard, often leading to resistant virus strains under long-term use. An alternative approach based on antiviral plant-derived compounds, such as quercetin and mangiferin, demonstrated an antiviral potential. In the present study, semisolid forms for cutaneous application of quercetin and mangiferin were designed and evaluated to treat HSV-1 infection. Phosphatidylcholine- and poloxamer-based gels were produced and characterized. Gel physical-chemical aspects were evaluated by rheological measurements and X-ray diffraction, evidencing the different thermoresponsive behaviors and supramolecular organizations of semisolid forms. Quercetin and mangiferin diffusion kinetics were compared in vitro by a Franz cell system, demonstrating the different gel efficacies to restrain the polyphenol diffusion. The capability of gels to control polyphenol antioxidant potential and stability was evaluated, indicating a higher stability and antioxidant activity in the case of quercetin loaded in poloxamer-based gel. Furthermore, a plaque reduction assay, conducted to compare the virucidal effect of quercetin and mangiferin loaded in gels against the HSV-1 KOS strain, demonstrated the suitability of poloxamer-based gel to prolong the polyphenol activity.

Indexed as

gelsHSV-1infection controlin vitro diffusionlecithinlocalized drug actionmangiferinpoloxamerpolyphenolsquercetin

Identifiers

PMID35055245
PMCPMC8780422
OpenAlexW4206277871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.